Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Octavian Bucur, M.D.

TitleResearch Fellow in Pathology (EXT)
InstitutionBeth Israel Deaconess Medical Center
DepartmentPathology
AddressBeth Israel Deaconess Medical Center
Pathology
330 Brookline Ave
Boston MA 02215
Phone617/667-3616

 Biography 
 awards and honors
2007 - 2008Lady Tata Memorial Trust Fellowship/Award, London, UK
2008 - American Association for Cancer Research-Aflac Scholar in Training Award
2008 - 2009Lady Tata Memorial Trust Fellowship/Award, London, UK (elongation)
2010 - IUBMB Fellowship to attend the Young Scientist Forum and OzBio2010 Conference, Melbourne, Australia

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Pennarun B, Gaidos G, Bucur O, Tinari A, Rupasinghe C, Jin T, Dewar R, Song K, Santos MT, Malorni W, Mierke D, Khosravi-Far R. killerFLIP: a novel lytic peptide specifically inducing cancer cell death. Cell Death Dis. 2013; 4:e894.
    View in: PubMed
  2. Bucur O, Stancu AL, Goganau I, Petrescu SM, Pennarun B, Bertomeu T, Dewar R, Khosravi-Far R. Combination of bortezomib and mitotic inhibitors down-modulate bcr-abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant bcr-abl-positive leukemic cells. PLoS One. 2013; 8(10):e77390.
    View in: PubMed
  3. Bucur O, Pennarun B, Stancu AL, Nadler M, Muraru MS, Bertomeu T, Khosravi-Far R. Poor antibody validation is a challenge in biomedical research: a case study for detection of c-FLIP. Apoptosis. 2013 Oct; 18(10):1154-62.
    View in: PubMed
  4. Liehn EA, Bucur O, Weber C. Role of microparticles as messengers enhancing stem cell activity after genetic engineering. Circ Res. 2012 Jul 20; 111(3):265-7.
    View in: PubMed
  5. Bucur O, Stancu AL, Khosravi-Far R, Almasan A. Analysis of apoptosis methods recently used in Cancer Research and Cell Death & Disease publications. Cell Death Dis. 2012; 3:e263.
    View in: PubMed
  6. Plati J, Bucur O, Khosravi-Far R. Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb). 2011 Apr; 3(4):279-96.
    View in: PubMed
  7. Singh A, Ye M, Bucur O, Zhu S, Tanya Santos M, Rabinovitz I, Wei W, Gao D, Hahn WC, Khosravi-Far R. Protein phosphatase 2A reactivates FOXO3a through a dynamic interplay with 14-3-3 and AKT. Mol Biol Cell. 2010 Mar 15; 21(6):1140-52.
    View in: PubMed
  8. Plati J, Bucur O, Khosravi-Far R. Dysregulation of apoptotic signaling in cancer: molecular mechanisms and therapeutic opportunities. J Cell Biochem. 2008 Jul 1; 104(4):1124-49.
    View in: PubMed
  9. Melet A, Song K, Bucur O, Jagani Z, Grassian AR, Khosravi-Far R. Apoptotic pathways in tumor progression and therapy. Adv Exp Med Biol. 2008; 615:47-79.
    View in: PubMed
  10. Bucur O, Ray S, Bucur MC, Almasan A. APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy. Front Biosci. 2006; 11:1549-68.
    View in: PubMed
  11. Ray S, Bucur O, Almasan A. Sensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor. Apoptosis. 2005 Dec; 10(6):1411-8.
    View in: PubMed
  12. Bucur O, Nat R, Cretoiu D, Popescu LM. Phagocytosis of apoptotic cells by microglia in vitro. J Cell Mol Med. 2001 Oct-Dec; 5(4):438-41.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Bucur's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_